Links:Lung cancer is the leading cause of cancer death in Delaware, across the country and around the world, claiming more lives than breast, colon and prostate cancers combined.
But one of the greatest challenges with lung cancer is that it can grow silently, often causing no noticeable symptoms until the disease has reached a more advanced stage. That’s why finding it early can make such a difference.
A simple, noninvasive test called low-dose CT screening can help detect lung cancer earlier, when there may be more options for treatment. Dr. Brian Nam, Chief of Thoracic Surgery and Interventional Pulmonology, and primary care physician and researcher Dr. Heather Bittner Fagan explain who should be screened, what to expect and how this powerful tool can help save lives.
Lung cancer screening can feel scary, but it can also be the moment that changes the story. If you're worried about your risk, find out more about how easily a low-dose CT scan may be able to help put your mind at ease.
Join us for National Lung Cancer Screening Day on Saturday, November 14, 2026.
Screenings are available from 8:30 a.m. to 1 p.m. at Helen F. Graham Cancer Center and Wilmington Hospital. Call 302-623-0552 to schedule your screening.
Brian Nam, M.D., is Chief of Thoracic Surgery and Interventional Pulmonology at ChristianaCare, where has been with the Helen F. Graham Cancer Center & Research Institute since 2012. He has collaborated on a number of research projects including the development of blood markers for lung cancer. He is also actively involved in lung cancer clinical trials at the Helen F. Graham Cancer Center, and has significant teaching experience.
Heather Bittner Fagan, M.D., MPH, FAFFP, is a practicing physician, faculty member and researcher in Family & Community Medicine at ChristianaCare. Dr. Fagan teaches family medicine residents as well as fellows, advanced practice nurses and medical students. She maintains an active clinical practice at Darley Green Family Medicine in Claymont, Delaware.
